Medoclav (Amoxicillin, Clavulanic Acid)

Amoxicillin interferes with bacterial cell wall synthesis by binding to penicillin‑binding proteins, causing cell lysis. Clavulanic acid inhibits β‑lactamase enzymes produced by resistant bacteria, protecting amoxicillin from degradation and extending its activity against a wider range of pathogens.

The dosage of Medoclav is individualized by the prescribing clinician based on the infection type, severity, patient age, weight, and renal function. Healthcare providers determine the appropriate strength, frequency, and duration according to clinical guidelines and patient needs.

Safety data for Medoclav in pregnancy and lactation are limited. It should be used only when clearly needed, after the prescriber evaluates the potential benefits against possible risks to the fetus or infant. Consultation with a healthcare professional is essential.

To request Medoclav, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Medoclav combines amoxicillin with clavulanic acid, offering protection against β‑lactamase‑producing bacteria that can inactivate amoxicillin alone. This broader spectrum makes Medoclav effective for infections where resistance to plain amoxicillin is common, though it may have a slightly higher incidence of gastrointestinal side effects.

Store Medoclav at temperatures below 25 °C, in its original packaging, and protect it from moisture. Keep the product out of reach of children and avoid exposure to direct sunlight or excessive heat to maintain its stability and potency.

Medoclav is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may reduce stomach upset. The exact administration schedule is determined by the prescribing clinician.

The most serious risks include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, Stevens‑Johnson syndrome, and significant liver enzyme elevations. Patients should seek immediate medical attention if they experience symptoms like rash, difficulty breathing, persistent diarrhea, or jaundice.

Medoclav should not be used by individuals with a known hypersensitivity to penicillins, clavulanic acid, or any component of the formulation. Caution is also advised for patients with a history of severe liver disease, certain blood disorders, or those taking medications that may interact adversely.